Could tumor spread through air spaces benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-institutional study

Background: The benefit of adjuvant chemotherapy (ACT) remains unknown for patients with stage I lung adenocarcinoma (ADC) with spread through air spaces (STAS). This study investigated the effect of adjuvant chemotherapy in stage I ADC/STAS-positive patients. Methods: A total of 3346 patients with...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Donglai Chen, Xiaofan Wang, Fuquan Zhang, Ruoshuang Han, Qifeng Ding, Xuejun Xu, Jian Shu, Fei Ye, Li Shi, Yiming Mao, Yongbing Chen, Chang Chen
Format: Artykuł
Język:English
Wydane: SAGE Publishing 2020-12-01
Seria:Therapeutic Advances in Medical Oncology
Dostęp online:https://doi.org/10.1177/1758835920978147